Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
Immunity
|
July 1, 2023
TCR-independent CD137 (4-1BB) signaling promotes CD8<sup>+</sup>-exhausted T cell proliferation and terminal differentiation
Andrea C Pichler, Nadège Carrié, Marine Cuisinier, et al.
Cancer Immunology Research
|
March 17, 2021
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy
Anne Montfort, Florie Bertrand, Julia Rochotte, et al.
Cancer Immunology Research
|
April 17, 2020
Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies
Camille-Charlotte Balança, Clara-Maria Scarlata, Marie Michelas, et al.
Cancer Cell
|
August 27, 2019
GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism
Laura Mondragón, Rana Mhaidly, Gian Marco De Donatis, et al.
Nature Communications
|
December 5, 2017
Dendrogenin A drives LXR to trigger lethal autophagy in cancers
Gregory Segala, Marion David, Philippe de Medina, et al.
The EMBO Journal
|
May 30, 2024
IL-27 maintains cytotoxic Ly6C<sup>+</sup> γδ T cells that arise from immature precursors
Robert Wiesheu, Sarah C Edwards, Ann Hedley, et al.
Nature Cancer
|
February 5, 2022
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia
Claudie Bosc, Estelle Saland, Aurélie Bousard, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
Immunity
|
July 1, 2023
TCR-independent CD137 (4-1BB) signaling promotes CD8<sup>+</sup>-exhausted T cell proliferation and terminal differentiation
Andrea C Pichler, Nadège Carrié, Marine Cuisinier, et al.
Cancer Immunology Research
|
March 17, 2021
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy
Anne Montfort, Florie Bertrand, Julia Rochotte, et al.
Cancer Immunology Research
|
April 17, 2020
Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies
Camille-Charlotte Balança, Clara-Maria Scarlata, Marie Michelas, et al.
Cancer Cell
|
August 27, 2019
GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism
Laura Mondragón, Rana Mhaidly, Gian Marco De Donatis, et al.
Nature Communications
|
December 5, 2017
Dendrogenin A drives LXR to trigger lethal autophagy in cancers
Gregory Segala, Marion David, Philippe de Medina, et al.
The EMBO Journal
|
May 30, 2024
IL-27 maintains cytotoxic Ly6C<sup>+</sup> γδ T cells that arise from immature precursors
Robert Wiesheu, Sarah C Edwards, Ann Hedley, et al.
Nature Cancer
|
February 5, 2022
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia
Claudie Bosc, Estelle Saland, Aurélie Bousard, et al.
Page
of 6